Revenue qualityDanger
매출 흑자인데 영업CF 적자 (OCF/매출 -130%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Kestra Medical Technologies, Ltd. Common Stock
KMTS · Nasdaq$25.54+1.59%
2026-09-04 closeKestra Medical Technologies, Ltd. Common Stock last closed at $25.54 (+1.59%) on 2026-09-04. Listed on Nasdaq; price, financials and dividends update daily after market close.
Loading chart…
Close
Super Strong RS 83 · top 17%
New high + volume — the real recordrecord · not a prediction
Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p
Every new-high-plus-volume pick we actually published (US market) — not this stock alone.
Signal history
| Date | Signal | +20 trading days |
|---|---|---|
A record, not a prediction.
How this is calculated
"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.
Trade plan
Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.
A calculator · not advice or a guarantee
Financials & valuation at a glance
Past reported results · not investment advice
More — deeper indicators
Financial safety
Reference indicatorAs of 2025Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -0.94
Distress
Grey
Safe
- Altman Z''
- -0.94
- Beneish M-Score
- —
- Sloan accrual
- -12.24%
Statistical flag unavailable
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
5/9Moderate
Piotroski measures year-over-year financial improvement, not absolute quality.
Financial improvement score5/9
Profitability
- Positive ROANot passed
- Positive OCFNot passed
- Improving ΔROAPass
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtPass
- Higher current ratioPass
- No new sharesPass
Efficiency
- Higher gross marginNot passed
- Higher asset turnoverNot passed
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
Balance sheetWarning
부채총계 급증 (+214%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- -177.8%
- Interest coverage
- -13.8x
- Return on equity (ROE)
- -55.4%
Operating margin −5pp
Operating lossInterest coverageBase -13.8x adverse case -14.1x
Return on equity (ROE)Base -55.4% adverse case -57%
Revenue −15%
Interest coverage riskInterest coverageBase -13.8x adverse case -11.7x
Return on equity (ROE)Base -55.4% adverse case -47.8%
Interest rate +2pp
Interest coverage riskInterest coverageBase -13.8x adverse case -11.1x
Return on equity (ROE)Base -55.4% adverse case -56.4%
Interest coverage limit
Already below the limit by 190.8ppInterest coverage limit at an operating margin of 12.9%
Interest expense coverage threshold
Recent filings
Filings for overseas stocks are on the way. For now we cover Korean stocks only.
About Kestra Medical Technologies, Ltd. Common Stock
- What technical signals does Kestra Medical Technologies, Ltd. Common Stock (KMTS) have?
- Kestra Medical Technologies, Ltd. Common Stock current technical signals: no active technical signal.
- Is Kestra Medical Technologies, Ltd. Common Stock a cup-and-handle pattern?
- No. Kestra Medical Technologies, Ltd. Common Stock has no valid cup-and-handle signal right now.
- What are Kestra Medical Technologies, Ltd. Common Stock's financials and valuation?
- Kestra Medical Technologies, Ltd. Common Stock's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Quantus Signal · live data · not investment advice · Privacy Policy